| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 47.238 | 52.152 | 107.537 | 81.970 | 81.318 | 106.374 | 119.774 | 142.579 | 165.473 |
| Total Income - EUR | - | 47.238 | 52.152 | 107.540 | 81.970 | 125.717 | 106.374 | 149.343 | 235.796 | 165.473 |
| Total Expenses - EUR | - | 8.510 | 18.301 | 19.756 | 18.320 | 68.319 | 43.877 | 84.758 | 111.660 | 88.954 |
| Gross Profit/Loss - EUR | - | 38.728 | 33.851 | 87.784 | 63.649 | 57.398 | 62.497 | 64.585 | 124.136 | 76.519 |
| Net Profit/Loss - EUR | - | 37.311 | 31.055 | 84.558 | 61.190 | 53.742 | 59.776 | 60.925 | 121.972 | 71.660 |
| Employees | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Uromedica Persu Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 6.487 | 62.409 | 58.726 | 57.147 | 44.690 | 27.151 | 46.119 | 184.719 | 138.937 |
| Current Assets | - | 36.951 | 10.367 | 52.023 | 14.996 | 143.313 | 99.249 | 35.702 | 23.031 | 46.693 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 4.536 | 7.409 | 40.367 | 10.798 | 117.441 | 69.453 | 10.248 | 10.076 | 17.314 |
| Cash | - | 32.415 | 2.958 | 11.655 | 4.198 | 25.872 | 29.796 | 25.454 | 12.955 | 29.379 |
| Shareholders Funds | - | 37.311 | 31.143 | 84.644 | 61.274 | 83.839 | 59.857 | 56.302 | 114.579 | 71.740 |
| Social Capital | - | 0 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 6.140 | 41.675 | 26.148 | 10.911 | 104.275 | 66.613 | 25.565 | 93.234 | 113.936 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Uromedica Persu Srl